{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:59:29Z","timestamp":1794265169603,"version":"4.9.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Vitamin D deficiency is one of the most common health issues in developed countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D<jats:sub>3<\/jats:sub> (25(OH)D<jats:sub>3<\/jats:sub>) levels that are too low due to the accumulation of vitamin D in adipose tissue. While the effects of a deficiency on the skeletal or immune system are known, the effects on the cardiovascular system are not yet clear. Our study investigates the effect of cholecalciferol supplementation in obese patients on selected biomarkers associated with cardiovascular diseases (CVDs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study enrolled 33 obese patients with insufficient 25(OH)D<jats:sub>3<\/jats:sub> levels. For three months, the subjects supplemented with cholecalciferol at a dose of 2000\u00a0IU\/day. Concentrations of nitric oxide (NO), vascular endothelial growth factor A (VEGF-A), leptin, trimethylamine N-oxide (TMAO) and soluble suppression of tumorigenicity 2 (sST2) were measured in baseline samples using ELISA (BioTek EPOCH). 25(OH)D<jats:sub>3<\/jats:sub> levels measured on Beckman Coulter DXI 800 by chemiluminescence method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After supplementation, 25(OH)D<jats:sub>3<\/jats:sub> levels increased significantly. Normal levels were achieved in most patients. A statistically significant reduction leptin and TMAO levels was observed. At the same time, NO and VEGF-A levels increased statistically significantly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study indicates that restoring normal 25(OH)D<jats:sub>3<\/jats:sub> levels in obese people reduces the concentration of pro-inflammatory factors associated with cardiovascular diseases. Reducing inflammation and the potential impact on vascular reactivity leads to the conclusion that cholecalciferol supplementation in obese patients may benefit the cardiovascular system.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12986-022-00666-4","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T07:02:55Z","timestamp":1651215775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential cardioprotective mechanisms of vitamin D?"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3401-8738","authenticated-orcid":false,"given":"Mateusz","family":"Ozorowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Wici\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Wr\u00f3bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fajkiel-Madajczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"666_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/864370","author":"ST Lugg","year":"2015","unstructured":"Lugg ST, Howells PA, Thickett DR. Optimal Vitamin D supplementation levels for cardiovascular disease protection. Dis Mark. 2015. https:\/\/doi.org\/10.1155\/2015\/864370.","journal-title":"Dis Mark"},{"key":"666_CR2","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3390\/ijms21186483","volume":"114","author":"S Bae","year":"2013","unstructured":"Bae S, Singh SS, Yu H, Lee JY, Cho BR, Kang PM. Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction. J Appl Physiol. 2013;114:979\u201387. https:\/\/doi.org\/10.3390\/ijms21186483.","journal-title":"J Appl Physiol"},{"issue":"25","key":"666_CR3","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1161\/CIRCULATIONAHA.106.655688","volume":"114","author":"VJ Dzau","year":"2006","unstructured":"Dzau VJ, Antman EM, Black HR, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes. Part I: pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation. 2006;114(25):2850\u201370.","journal-title":"Circulation"},{"issue":"2","key":"666_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.advms.2015.12.007","volume":"61","author":"J Dadonien\u0117","year":"2016","unstructured":"Dadonien\u0117 J, \u010cypien\u0117 A, Rink\u016bnien\u0117 E, Badarien\u0117 J, Burca J, Sakait\u0117 I, Kalinauskait\u0117 G, Kumpauskait\u0117 V, Laucevi\u010dius A. Vitamin D and functional arterial parameters in postmenopausal women with metabolic syndrome. Adv Med Sci. 2016;61(2):224\u201330.","journal-title":"Adv Med Sci"},{"issue":"19","key":"666_CR5","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1113\/jphysiol.2011.214726","volume":"589","author":"M Tare","year":"2011","unstructured":"Tare M, Emmett SJ, Coleman HA, Skordilis C, Eyles DW, Morley R, Parkington H. Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J Physiol. 2011;589(19):4777\u201386.","journal-title":"J Physiol"},{"issue":"4","key":"666_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","volume":"117","author":"TJ Wang","year":"2008","unstructured":"Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingellson E, Lanier K, Benjamin EJ, D\u2019Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503\u201311.","journal-title":"Circulation"},{"issue":"7","key":"666_CR7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.amjcard.2010.05.027","volume":"106","author":"JL Anderson","year":"2010","unstructured":"Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappe DL, Muhlestein JB. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106(7):963\u20138.","journal-title":"Am J Cardiol"},{"key":"666_CR8","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s00198-013-2281-1","volume":"24","author":"LA Beveridge","year":"2013","unstructured":"Beveridge LA, Witham MD. Vitamin D and the cardiovascular system. Osteoporos Int. 2013;24:2167\u201380. https:\/\/doi.org\/10.1007\/s00198-013-2281-1.","journal-title":"Osteoporos Int"},{"key":"666_CR9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/ajcn\/72.3.690","volume":"72","author":"J Wortsman","year":"2000","unstructured":"Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690\u20133. https:\/\/doi.org\/10.1093\/ajcn\/72.3.690.","journal-title":"Am J Clin Nutr"},{"key":"666_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jsbmb.2006.12.032","volume":"103","author":"H Florez","year":"2007","unstructured":"Florez H, Martinez R, Chacra W, Strickman-Stein N, Levis S. Outdoor exercise reduces the risk of hypovitaminosis D in the obese. J Steroid Biochem Mol Biol. 2007;103:679\u201381. https:\/\/doi.org\/10.1016\/j.jsbmb.2006.12.032.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"666_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.numecd.2006.04.002","volume":"17","author":"G Targher","year":"2007","unstructured":"Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, Arcaro G. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17:517\u201324. https:\/\/doi.org\/10.1016\/j.numecd.2006.04.002.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"suppl 1","key":"666_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1467-789X.2007.00316.x","volume":"8","author":"P Trayhurn","year":"2007","unstructured":"Trayhurn P. Adipocyte biology. Obes Rev. 2007;8(suppl 1):41\u20134. https:\/\/doi.org\/10.1111\/j.1467-789X.2007.00316.x.","journal-title":"Obes Rev"},{"key":"666_CR13","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1096\/fj.12-221812","volume":"27","author":"M Bagchi","year":"2013","unstructured":"Bagchi M, Kim LA, Boucher J, Walshe TE, Kahn CR, D\u2019Amore PA. Vascular endothelial growth factor is important for brown adipose tissue development and maintenance. FASEB J. 2013;27:3257\u201371. https:\/\/doi.org\/10.1096\/fj.12-221812.","journal-title":"FASEB J"},{"issue":"A","key":"666_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neuropharm.2014.12.023","volume":"96","author":"A Aguilar-Valles","year":"2015","unstructured":"Aguilar-Valles A, Inoue W, Rummel C, Luheshi GN. Obesity, adipokines and neuroinflammation. Neuropharmacology. 2015;96(A):124\u201334. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.12.023.","journal-title":"Neuropharmacology"},{"issue":"24","key":"666_CR15","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1093\/eurheartj\/ehn387","volume":"29","author":"GR Hajer","year":"2008","unstructured":"Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29(24):2959\u201371. https:\/\/doi.org\/10.1093\/eurheartj\/ehn387.","journal-title":"Eur Heart J"},{"issue":"5","key":"666_CR16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","volume":"32","author":"S Gordon","year":"2010","unstructured":"Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32(5):593\u2013604. https:\/\/doi.org\/10.1016\/j.immuni.2010.05.007.","journal-title":"Immunity"},{"issue":"9","key":"666_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006347","volume":"6","author":"ML Chen","year":"2017","unstructured":"Chen ML, Zhu XH, Ran L, Lang HD, Yi L, Mi MT. Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. J Am Heart Assoc. 2017;6(9): e006347. https:\/\/doi.org\/10.1161\/JAHA.117.006347.","journal-title":"J Am Heart Assoc"},{"key":"666_CR18","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/nu11061310","volume":"11","author":"L Barrea","year":"2019","unstructured":"Barrea L, Muscogiuri G, Annunziata G, Laudisio D, Alteriis G, Tenore GC, Colao A, Savastano S. A new light on vitamin D in obesity: a novel association with trimethylamine-N-oxide (TMAO). Nutrients. 2019;11:1310. https:\/\/doi.org\/10.3390\/nu11061310.","journal-title":"Nutrients"},{"issue":"1","key":"666_CR19","first-page":"1","volume":"10","author":"F Guarneri","year":"2021","unstructured":"Guarneri F, Custurone P, Papaianni V, Gangemi S. Involvement of RAGE and oxidative stress in inflammatory and infectious skin diseases. Antioxidants (Basel). 2021;10(1):1\u201314.","journal-title":"Antioxidants (Basel)"},{"issue":"8","key":"666_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2174\/1381612043452857","volume":"10","author":"WC Hooper","year":"2004","unstructured":"Hooper WC. The relationship between inflammation and the anticoagulant pathway: the emerging role of endothelial nitric oxide synthase (eNOS). Curr Pharm Des. 2004;10(8):923\u20137. https:\/\/doi.org\/10.2174\/1381612043452857.","journal-title":"Curr Pharm Des"},{"key":"666_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/apha.12182","volume":"210","author":"XQ Xiong","year":"2014","unstructured":"Xiong XQ, Chen WW, Zhu GQ. Adipose afferent reflex: Sympathetic activation and obesity hypertension. Acta Physiol. 2014;210:468\u201378.","journal-title":"Acta Physiol"},{"issue":"15","key":"666_CR22","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.3390\/ijms21155294","volume":"21","author":"M Braile","year":"2020","unstructured":"Braile M, Marcella S, Cristinziano L, Galdiero MR, Modestino L, Ferrara AL, Varricchi G, Marone G, Loffredo S. VEGF-A in cardiomyocytes and heart diseases. Int J Mol Sci. 2020;21(15):5294. https:\/\/doi.org\/10.3390\/ijms21155294.","journal-title":"Int J Mol Sci"},{"issue":"7 supl.","key":"666_CR23","doi-asserted-by":"publisher","first-page":"3B","DOI":"10.1016\/j.amjcard.2015.01.034","volume":"115","author":"DA Pascual-Figal","year":"2015","unstructured":"Pascual-Figal DA, Januzzi JL. The biology of ST2: the international ST2 consensus panel. am J Cardiol. 2015;115(7 supl.):3B-7B.","journal-title":"am J Cardiol"},{"key":"666_CR24","first-page":"100887","volume":"37","author":"C Ip","year":"2021","unstructured":"Ip C, Luk KS, Yuen VLC, Chiang L, Chan CK, Ho K, Gong M, Lee TTL, Leung KSK, Roever L, Bazoukis G, Lampropoulos K, Li KHC, Tse G, Liu T. International Health Informatics Study (IHIS) Network. Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: a systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2021;37:100887.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"4","key":"666_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1155\/2019\/4145821","volume":"14","author":"I Gotsman","year":"2012","unstructured":"Gotsman I, Shauer A, Zwas DR, et al. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail. 2012;14(4):357\u201366. https:\/\/doi.org\/10.1155\/2019\/4145821.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"666_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jash.2015.01.009","volume":"9","author":"OU Ozcan","year":"2015","unstructured":"Ozcan OU, Gurlek A, Gursoy E, Gerede DM, Erol C. Relation of vitamin D deficiency and new-onset atrial fibrillation among hypertensive patients. J Am Soc Hypertens. 2015;9(4):307\u201312. https:\/\/doi.org\/10.1016\/j.jash.2015.01.009.","journal-title":"J Am Soc Hypertens"},{"key":"666_CR27","doi-asserted-by":"publisher","unstructured":"Bjelakovic G, Gluud LL, Nikolova D , et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014;10(1):Article ID CD007470. https:\/\/doi.org\/10.1002\/14651858.CD007470.pub3.","DOI":"10.1002\/14651858.CD007470.pub3"},{"issue":"2","key":"666_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3945\/ajcn.110.008763","volume":"94","author":"Q Sun","year":"2011","unstructured":"Sun Q, Shi L, Rimm EB, Giovannucci EL, Hu FB, Manson JE, Rexrode KM. Vitamin D intake and risk of cardiovascular disease in US men and women. Am J Clin Nutr. 2011;94(2):534\u201342. https:\/\/doi.org\/10.3945\/ajcn.110.008763.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"666_CR29","first-page":"359","volume":"19","author":"F Modarresi-Ghazani","year":"2016","unstructured":"Modarresi-Ghazani F, Hejazi ME, Gharekhani A, Entezari-Maleki T. Role of vitamin D in cardiovascular disease. Arch Iran Med. 2016;19(5):359\u201362.","journal-title":"Arch Iran Med"},{"issue":"2","key":"666_CR30","first-page":"40","volume":"60","author":"V Touskova","year":"2011","unstructured":"Touskova V, Haluzik M. Insulin resistance and nitric oxide: molecular mechanisms and pathophysiological associations. Cesk Fysiol. 2011;60(2):40\u20137.","journal-title":"Cesk Fysiol"},{"key":"666_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1489132","volume":"1489132","author":"NM Al-Daghri","year":"2018","unstructured":"Al-Daghri NM, Bukhari I, Yakout SM, Sabico S, Khattak MNK, Aziz I, Alokail MS. Associations of serum nitric oxide with vitamin D and other metabolic factors in apparently healthy adolescents. Biomed Res Int. 2018;1489132:1\u20137.","journal-title":"Biomed Res Int"},{"key":"666_CR32","first-page":"1","volume":"6802562","author":"Z Huang","year":"2020","unstructured":"Huang Z, Liu L, Huang S, Li J, Feng S, Huang N, Ai Z, Long W, Jiang L. Vitamin D (1,25-(OH)2D3) improves endothelial progenitor cells function via enhanced NO secretion in systemic lupus erythematosus. Cardiol Res Pract. 2020;6802562:1\u20138.","journal-title":"Cardiol Res Pract"},{"issue":"1","key":"666_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/me.2013-1252","volume":"28","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova O, Slavic S, Zeitz U, Riesen SC, Heppelmann MS, Ambrisko TD, Markovic M, Kuebler WM, Erben RG. Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol. 2014;28(1):53\u201364.","journal-title":"Mol Endocrinol"},{"key":"666_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.00148","volume":"11","author":"V Tran","year":"2020","unstructured":"Tran V, De Silva TM, Sobey CG, Lim K, Drummond GR, Vinh A, Jelinic M. The vascular consequences of metabolic syndrome: rodent models, endothelial dysfunction, and current therapies. Front Pharmacol. 2020;11:1\u201310.","journal-title":"Front Pharmacol"},{"issue":"4","key":"666_CR35","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1152\/ajpheart.00631.2020","volume":"319","author":"ST Wolf","year":"2020","unstructured":"Wolf ST, Jablonski NG, Ferguson SB, Alexander LM, Kenney WL. Four weeks of vitamin D supplementation improves nitric oxide-mediated microvascular function in college-aged African Americans. Am J Physiol Heart Circ Physiol. 2020;319(4):906\u201314.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"666_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-0044-101355","volume":"50","author":"M Akbari","year":"2018","unstructured":"Akbari M, Ostadmohammadi V, Lankarani KB, Tabrizi R, Kolahdooz F, Heydari ST, Kavari SH, Mirhosseini N, Mafi A, Dastorani M, Asemi Z. The effects of vitamin D supplementation on biomarkers of inflammation and oxidative stress among women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Horm Metab Res. 2018;50(4):271\u20139.","journal-title":"Horm Metab Res"},{"issue":"8","key":"666_CR37","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1590\/0004-2730000003390","volume":"58","author":"R Zeng","year":"2014","unstructured":"Zeng R, et al. Association of leptin levels with pathogenetic risk of coronary heart disease and stroke: a meta-analysis. Arquivos brasileiros de endocrinologia e metabologia. 2014;58(8):817\u201323. https:\/\/doi.org\/10.1590\/0004-2730000003390.","journal-title":"Arquivos brasileiros de endocrinologia e metabologia"},{"issue":"2","key":"666_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1365-2796.2004.01351.x","volume":"256","author":"S Soderberg","year":"2004","unstructured":"Soderberg S, Stegmayr B, Stenlund H, Sjostrom LG, Agren A, Johansson L, et al. Leptin, but not adiponectin, predicts stroke in males. J Internal Med. 2004;256(2):128\u201336. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01351.x.","journal-title":"J Internal Med"},{"issue":"1","key":"666_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2265.2009.03627.x","volume":"72","author":"J Liu","year":"2010","unstructured":"Liu J, Butler KR, Buxbaum SG, Sung JH, Campbell BW, Taylor HA. Leptinemia and its association with stroke and coronary heart disease in the Jackson Heart Study. Clin Endocrinol. 2010;72(1):32\u20137. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03627.x.","journal-title":"Clin Endocrinol"},{"issue":"25","key":"666_CR40","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1161\/hc5001.101061","volume":"104","author":"AM Wallace","year":"2001","unstructured":"Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation. 2001;104(25):3052\u20136.","journal-title":"Circulation"},{"issue":"9","key":"666_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1089\/met.2020.0065","volume":"18","author":"SC Lu","year":"2020","unstructured":"Lu SC, Akanji AO. Leptin, obesity, and hypertension: a review of pathogenetic mechanisms. Metab Syndr Relat Disord. 2020;18(9):399\u2013405.","journal-title":"Metab Syndr Relat Disord"},{"issue":"8","key":"666_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu9080799","volume":"9","author":"P Manoy","year":"2017","unstructured":"Manoy P, Yuktanandana P, Tanavalee A, Anomasiri W, Ngarmukos S, Tanpowpong T, Honsawek S. Vitamin D supplementation improves quality of life and physical performance in osteoarthritis patients. Nutrients. 2017;9(8):1\u201313.","journal-title":"Nutrients"},{"issue":"9","key":"666_CR43","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1210\/jc.2014-1714","volume":"99","author":"KS Jones","year":"2014","unstructured":"Jones KS, Assar S, Harnpanich D, Bouillon R, Lambrechts D, Prentice A, Schoenmakers I. 25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype. J Clin Endocrinol Metab. 2014;99(9):3373\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"666_CR44","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.drudis.2012.04.007","volume":"17","author":"I Falcao-Pires","year":"2012","unstructured":"Falcao-Pires I, Castro-Chaves P, Miranda-Silva DI, Lourenco A, Leite-Moreira AF. Physiological, pathological and potential therapeutic roles of adipokines. Drug Discov Today. 2012;17:880\u20139.","journal-title":"Drug Discov Today"},{"issue":"1","key":"666_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00394-019-01899-5","volume":"59","author":"A Mousa","year":"2020","unstructured":"Mousa A, Naderpoor N, Wilson K, Plebanski M, de Courten MPJ, Scragg R, de Courten B. Vitamin D supplementation increases adipokine concentrations in overweight or obese adults. Eur J Nutr. 2020;59(1):195\u2013204.","journal-title":"Eur J Nutr"},{"key":"666_CR46","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.biopha.2017.11.016","volume":"97","author":"J Geng","year":"2018","unstructured":"Geng J, et al. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK\/JNK pathway. Biomed Pharmacother Biomedecine pharmacotherapie. 2018;97:941\u20137. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.016.","journal-title":"Biomed Pharmacother Biomedecine pharmacotherapie"},{"issue":"5","key":"666_CR47","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.21037\/apm-20-296","volume":"9","author":"Z Dong","year":"2020","unstructured":"Dong Z, et al. The correlation between plasma trimethylamine N-oxide level and heart failure classification in northern Chinese patients. Ann Palliat Med. 2020;9(5):2862\u201371. https:\/\/doi.org\/10.21037\/apm-20-296.","journal-title":"Ann Palliat Med"},{"key":"666_CR48","doi-asserted-by":"publisher","first-page":"1578320","DOI":"10.1155\/2018\/1578320","volume":"2018","author":"Z Dong","year":"2018","unstructured":"Dong Z, Liang Z, Guo M, Hu S, Shen Z, Hai X. The association between plasma levels of trimethylamine N-oxide and the risk of coronary heart disease in Chinese patients with or without type 2 diabetes mellitus. Dis Mark. 2018;2018:1578320. https:\/\/doi.org\/10.1155\/2018\/1578320.","journal-title":"Dis Mark"},{"issue":"6","key":"666_CR49","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.amjcard.2018.12.018","volume":"123","author":"P Zhou","year":"2019","unstructured":"Zhou P, Li J, Zhou J. Relation of circulating trimethylamine n-oxide with coronary atherosclerotic burden in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2019;123(6):894\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2018.12.018.","journal-title":"Am J Cardiol"},{"issue":"1","key":"666_CR50","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12944-018-0939-6.PMID:30567573;PMCID:PMC6300890","volume":"17","author":"L Ding","year":"2018","unstructured":"Ding L, Chang M, Guo Y, Zhang L, Xue C, Yanagita T, Zhang T, Wang Y. Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism. Lipids Health Dis. 2018;17(1):286. https:\/\/doi.org\/10.1186\/s12944-018-0939-6.PMID:30567573;PMCID:PMC6300890.","journal-title":"Lipids Health Dis"},{"issue":"6","key":"666_CR51","doi-asserted-by":"publisher","first-page":"BSR20190515","DOI":"10.1042\/BSR20190515","volume":"39","author":"M Rexidamu","year":"2019","unstructured":"Rexidamu M, Li H, Jin H, Huang J. Serum levels of trimethylamine-N-oxide in patients with ischemic stroke. Biosci Rep. 2019;39(6):BSR20190515. https:\/\/doi.org\/10.1042\/BSR20190515.","journal-title":"Biosci Rep"},{"issue":"18","key":"666_CR52","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","volume":"64","author":"WH Tang","year":"2014","unstructured":"Tang WH, Wang Z, Fan Y, Levison B, Hazen JE, Donahue LM. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J Am Coll Cardiol. 2014;64(18):1908\u201314. https:\/\/doi.org\/10.1016\/j.jacc.2014.02.617.","journal-title":"J Am Coll Cardiol"},{"key":"666_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6786302","author":"A Huang","year":"2020","unstructured":"Huang A, et al. Serum VEGF: diagnostic value of acute coronary syndrome from stable angina pectoris and prognostic value of coronary artery disease. Cardiol Res Pract. 2020. https:\/\/doi.org\/10.1155\/2020\/6786302.","journal-title":"Cardiol Res Pract"},{"key":"666_CR54","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.12659\/msm.894803","volume":"21","author":"X Han","year":"2015","unstructured":"Han X, et al. Serum VEGF spredicts worse clinical outcome of patients with coronary heart disease after percutaneous coronary intervention therapy. Med Sci Monit. 2015;21:3247\u201351. https:\/\/doi.org\/10.12659\/msm.894803.","journal-title":"Med Sci Monit"},{"issue":"23","key":"666_CR55","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1136\/heartjnl-2015-309155","volume":"102","author":"BM Kaess","year":"2016","unstructured":"Kaess BM, et al. Circulating vascular endothelial growth factor and the risk of cardiovascular events. Heart. 2016;102(23):1898\u2013901. https:\/\/doi.org\/10.1136\/heartjnl-2015-309155.","journal-title":"Heart"},{"issue":"6","key":"666_CR56","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1530\/EC-19-0090","volume":"8","author":"V Francic","year":"2019","unstructured":"Francic V, Keppel M, Schwetz V, Trummer C, Pandis M, Borzan V, Gr\u00fcbler MR, Verheyen ND, Kleber ME, Delgado G, Moissl AP, Dieplinger B, M\u00e4rz W, Tomaschitz A, Pilz S, Obermayer-Pietsch B. Are soluble ST2 levels influenced by vitamin D and\/or the seasons? Endocr Connect. 2019;8(6):691\u2013700.","journal-title":"Endocr Connect"},{"key":"666_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mehy.2016.09.001","volume":"95","author":"S Sarkar","year":"2016","unstructured":"Sarkar S, et al. Vitamin D regulates the production of vascular endothelial growth factor: a triggering cause in the pathogenesis of rheumatic heart disease? Med Hypoth. 2016;95:62\u20136. https:\/\/doi.org\/10.1016\/j.mehy.2016.09.001.","journal-title":"Med Hypoth"},{"issue":"1","key":"666_CR58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2008.08.020","volume":"204","author":"A Cardus","year":"2009","unstructured":"Cardus A, et al. 1,25-Dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis. 2009;204(1):85\u20139. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.08.020.","journal-title":"Atherosclerosis"},{"issue":"1\u20133","key":"666_CR59","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jsbmb.2008.09.006","volume":"112","author":"J Li","year":"2008","unstructured":"Li J, et al. 1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol. 2008;112(1\u20133):122\u20136. https:\/\/doi.org\/10.1016\/j.jsbmb.2008.09.006.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"666_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600358","author":"R Obeid","year":"2017","unstructured":"Obeid R, et al. Plasma trimethylamine-N-oxide following supplementation with vitamin D or D plus B vitamins. Mol Nutr Food Res. 2017. https:\/\/doi.org\/10.1002\/mnfr.201600358.","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"666_CR61","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5114\/aoms.2013.33181","volume":"9","author":"M Coelho","year":"2013","unstructured":"Coelho M, et al. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013;9(2):191\u2013200. https:\/\/doi.org\/10.5114\/aoms.2013.33181.","journal-title":"Arch Med Sci"},{"issue":"6","key":"666_CR62","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1210\/jc.2004-0395","volume":"89","author":"EE Kershaw","year":"2004","unstructured":"Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548\u201356. https:\/\/doi.org\/10.1210\/jc.2004-0395.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"666_CR63","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1194\/jlr.M700505-JLR200","volume":"50","author":"L Wang","year":"2009","unstructured":"Wang L, et al. Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J Lip Res. 2009;50(2):204\u201313. https:\/\/doi.org\/10.1194\/jlr.M700505-JLR200.","journal-title":"J Lip Res"},{"issue":"2","key":"666_CR64","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF02915808","volume":"11","author":"T Gainsford","year":"1999","unstructured":"Gainsford T, Alexander WS. A role for leptin in hemopoieses? Mol Biotechnol. 1999;11(2):149\u201358. https:\/\/doi.org\/10.1007\/BF02915808.","journal-title":"Mol Biotechnol"},{"issue":"8","key":"666_CR65","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.3390\/ijerph18084296","volume":"18","author":"N Farmer","year":"2021","unstructured":"Farmer N, et al. Neighborhood environment associates with trimethylamine-N-oxide (TMAO) as a cardiovascular risk marker. Int J Environ Res Public Health. 2021;18(8):4296. https:\/\/doi.org\/10.3390\/ijerph18084296.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"666_CR66","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2337\/db11-0832","volume":"61","author":"I Elias","year":"2012","unstructured":"Elias I, et al. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. Diabetes. 2012;61(7):1801\u201313. https:\/\/doi.org\/10.2337\/db11-0832.","journal-title":"Diabetes"},{"issue":"6","key":"666_CR67","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1210\/en.2014-1905","volume":"156","author":"MJ During","year":"2015","unstructured":"During MJ, et al. Adipose VEGF links the white-to-brown fat switch with environmental, genetic, and pharmacological stimuli in male mice. Endocrinology. 2015;156(6):2059\u201373. https:\/\/doi.org\/10.1210\/en.2014-1905.","journal-title":"Endocrinology"},{"issue":"4","key":"666_CR68","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.molmet.2014.03.010","volume":"3","author":"K Sun","year":"2014","unstructured":"Sun K, et al. Brown adipose tissue derived VEGF-A modulates cold tolerance and energy expenditure. Mol Metab. 2014;3(4):474\u201383. https:\/\/doi.org\/10.1016\/j.molmet.2014.03.010.","journal-title":"Mol Metab"},{"issue":"4","key":"666_CR69","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/scd.2013.0268","volume":"23","author":"MM Bekhite","year":"2014","unstructured":"Bekhite MM, et al. Hypoxia, leptin, and vascular endothelial growth factor stimulate vascular endothelial cell differentiation of human adipose tissue-derived stem cells. Stem Cells Dev. 2014;23(4):333\u201351. https:\/\/doi.org\/10.1089\/scd.2013.0268.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"666_CR70","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmet.2012.12.010","volume":"17","author":"H-K Sung","year":"2013","unstructured":"Sung H-K, et al. Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis. Cell Metab. 2013;17(1):61\u201372. https:\/\/doi.org\/10.1016\/j.cmet.2012.12.010.","journal-title":"Cell Metab"},{"issue":"1","key":"666_CR71","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.metabol.2015.09.012","volume":"65","author":"K Mahdaviani","year":"2016","unstructured":"Mahdaviani K, et al. Autocrine effect of vascular endothelial growth factor-A is essential for mitochondrial function in brown adipocytes. Metab Clin Exp. 2016;65(1):26\u201335. https:\/\/doi.org\/10.1016\/j.metabol.2015.09.012.","journal-title":"Metab Clin Exp"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-022-00666-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-022-00666-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-022-00666-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T07:06:47Z","timestamp":1651216007000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionandmetabolism.biomedcentral.com\/articles\/10.1186\/s12986-022-00666-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["666"],"URL":"https:\/\/doi.org\/10.1186\/s12986-022-00666-4","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"8 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Ethics Committee of Nicolaus Copernicus University Collegium Medicum (Approval Number KB48\/2019 of 29.01.2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}